Editorial Comment: Fifty per cent of all HF patients involves Diastolic Heart Failure or HF with conserved ventricular function. This study aimed at evaluating the efficacy and safety of 25mg spironolactone after a year of therapy. Results showed improved diastolic function, induced structural inverse remodelling, reduced neuroendocrine activation and reduced blood pressure (effects on cardiac structure and function remained significant after adjusting for blood pressure changes). Authors concluded that, in addition to safety, this drug is an effective alternative to treat these patients
aldoHF-slides
B. Pieske
2012-08-25
Original title: Aldo-DHF: Aldosterone Receptor Blockade in Diastolic Heart Failure
